Blood News and Research

RSS

20% of childhood AML cases associated with rare genetic changes inherited through family bloodlines

It's a diagnosis you never want to hear: Acute Myeloid Leukemia (AML). These three words represent a devastating diagnosis of childhood cancer with dire consequences for many families.

21 Mar 2022

New test greatly simplifies the diagnosis of allergies

Although allergies are widespread, their diagnosis is complex and, depending on the type of allergy, the prospects of success with therapy are not always clear.

21 Mar 2022

CHOP and Penn Medicine join hands to address environmental hazards and protect vulnerable children

Children in the Greater Philadelphia area face a number of environmental threats to their health, including lead poisoning, asthma from air pollution, and exposure to endocrine disrupting chemicals.

21 Mar 2022

TTUHSC secures $1.87 million grant to investigate the impact of vitamin A depletion on Alzheimer’s disease

Ongoing research suggests that an accumulation of toxic reactive oxygen species (ROS) in the area of the brain known as the hippocampal dentate gyrus may begin early on in patients with Alzheimer's disease.

21 Mar 2022

LJI study may open the door to new Parkinson's treatments and diagnostics

Scientists at La Jolla Institute for Immunology have found that people with Parkinson's disease have a clear "genetic signature" of the disease in their memory T cells.

21 Mar 2022

NIH launches Molecular Characterization Initiative for pediatric tumors

In support of President Biden's Cancer Moonshot℠ goal of fostering data sharing in cancer research, the National Cancer Institute, part of the National Institutes of Health, has launched the Molecular Characterization Initiative for pediatric tumors.

21 Mar 2022

Influence of vitamin D and age on first SARS-CoV-2 vaccine dose efficacy

Researchers illustrated that vitamin D status and age influence antibody response following the initial dose of coronavirus disease 2019 vaccination.

21 Mar 2022

Safety and antibody responses to COVID-19 vaccines in an older community

Researchers evaluated the antibody responses in an older cohort following COVID-19 vaccination and compared them to a younger cohort.

21 Mar 2022

Study explores prevalence and symptom trajectory of long COVID

A new study estimated long-term COVID-19, or, long COVID, and the trajectory of disease symptoms in a representative sample in the US.

21 Mar 2022

Study assesses human milk antibodies against common human coronaviruses following COVID-19 infection and vaccination

A recent study demonstrated that COVID-19 and its vaccination generates cross-reactive antibodies against human coronaviruses in lactating mothers.

21 Mar 2022

Biological timeline of COVID-19 immune recovery described in new research

In a recent study published on the bioRxiv* preprint server, a group of researchers from the University of California, San Francisco, looked at intra-patient immunological changes over time to see if there were any changes in immune responses associated with successful COVID-19 resolution.

21 Mar 2022

Low levels of SARS-CoV-2 viremia associated with ‘COVID placentitis’ and stillbirths

Researchers hypothesize that patients with COVID placentitis were more likely to contract viremia.

20 Mar 2022

Novel device uses tiny worms to detect lung cancer cells

Dogs can use their incredible sense of smell to sniff out various forms of cancer in human breath, blood and urine samples.

20 Mar 2022

Response to COVID-19 boosters in seronegative multiple sclerosis patients

Researchers report humoral T-cell responses in seronegative MS patients after receiving a third COVID-19 booster vaccine dose.

20 Mar 2022

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

A Phase I/Ib trial conducted by the National Cancer Institute (NCI) National Clinical Trials Network (NCTN) group NRG Oncology, NRG-GY017, concluded that the addition of the immunotherapy drug atezolizumab prior to and concurrently given with chemoradiation (CRT) treatment was safe for women with node-positive, locally advanced cervical cancer.

19 Mar 2022

Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

A combination therapy that targets cancer cells from within and without caused tumors to shrink or stabilize in 75% of patients with recurrent or persistent estrogen receptor- (ER-) positive endometrial cancer, results from a recent clinical trial show.

19 Mar 2022

Blood News and Research

20% of childhood AML cases associated with rare genetic changes inherited through family bloodlines

New test greatly simplifies the diagnosis of allergies

CHOP and Penn Medicine join hands to address environmental hazards and protect vulnerable children

TTUHSC secures $1.87 million grant to investigate the impact of vitamin A depletion on Alzheimer’s disease

LJI study may open the door to new Parkinson's treatments and diagnostics

NIH launches Molecular Characterization Initiative for pediatric tumors

Influence of vitamin D and age on first SARS-CoV-2 vaccine dose efficacy

Safety and antibody responses to COVID-19 vaccines in an older community

Study explores prevalence and symptom trajectory of long COVID

Study assesses human milk antibodies against common human coronaviruses following COVID-19 infection and vaccination

Biological timeline of COVID-19 immune recovery described in new research

Low levels of SARS-CoV-2 viremia associated with ‘COVID placentitis’ and stillbirths

Novel device uses tiny worms to detect lung cancer cells

Response to COVID-19 boosters in seronegative multiple sclerosis patients

Trial shows safety and immunogenicity of immunotherapy with chemoradiation in cervical cancer patients

Combination therapy shows promising results in patients with recurrent ER-positive endometrial cancer

Dyspnea or fatigue can lead to worse outcomes than chest pain for heart attack patients

Women less likely to receive lifesaving intervention for cardiogenic shock than men

Natural circulating antibodies last for at least seven months in children infected with COVID-19

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News